Salarius Pharmaceuticals Inc Sustainability Reports
A clinical-stage biotechnology company that leverages artificial intelligence and machine learning infrastructure to develop peptide conjugate therapeutics and epigenetic-based cancer treatments.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
1 reports from 2023 to 2023
Company Profile
A clinical-stage biotechnology company that leverages artificial intelligence and machine learning infrastructure to develop peptide conjugate therapeutics and epigenetic-based cancer treatments.
Reports
1 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
Years